Retrovirus and malignant lymphoma in homosexual men
- 11 October 1985
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 254 (14) , 1921-1925
- https://doi.org/10.1001/jama.254.14.1921
Abstract
We report malignant lymphoma in 27 homosexual men, of whom 22 had high-grade lymphomas (B-cell immunoblastic sarcoma or small non-cleaved lymphoma) and 5 had low-grade disease. Antibody to human T-cell lymphotropic virus type II (HTLV-III) was present in 13 (87%) of 15 with high-grade lymphoma and in two (40%) of five with low-grade disease. In contrast, only one (9%) of 11 "control" heterosexual patients with high-grade lymphoma had antibody to HTLV-III, while such antibody was found in none of 40 asymptomatic heterosexual controls and in 17 (55%) of 31 asymptomatic homosexual men. Of the homosexual lymphoma patients, 85% presented with disease in extranodal sites, including the central nervous system and rectum, and 81% had reversed T-helper/suppressor ratios. Median survival, despite treatment, is eight months. The acquired immunodeficiency syndrome-related lymphomas in homosexual men are extranodal, high-grade, B-lymphoid tumors, associated with exposure to HTLV-III and unusual clinical characteristics.This publication has 5 references indexed in Scilit:
- CYTOFLUOROGRAPHIC ANALYSIS OF LYMPH-NODES FROM PATIENTS WITH THE PERSISTENT GENERALIZED LYMPHADENOPATHY (PGL) SYNDROME1985
- Development of B-Cell Lymphoma in Homosexual Men Clinical and Immunologic FindingsAnnals of Internal Medicine, 1984
- OUTBREAK OF BURKITT'S-LIKE LYMPHOMA IN HOMOSEXUAL MENThe Lancet, 1982
- Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 casesCancer, 1982
- Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, and Prednisone (BACOP) Combination Chemotherapy in the Treatment of Advanced Diffuse Histiocytic LymphomaAnnals of Internal Medicine, 1976